https://www.selleckchem.com/products/torin-1.html
ologic features of colon biopsies (Geboes score) to be an independent risk factor for progression of UC in the first 36 months after biopsy. The value of a cancer screening programs is defined by its balance of benefits and harms; however, there are few data evaluating both attributes for hepatocellular carcinoma (HCC) surveillance. We aimed to characterize benefits and harms of HCC surveillance in a large prospective cohort of patients with cirrhosis. We conducted a secondary analysis of a clinical trial evaluating HCC surveillance amo